Probiotics in the treatment of helicobacter pylori infection
https://doi.org/10.21518/2079-701X-2015-14-69-72
Abstract
The article is an overview of the effects of probiotics in eradication therapy, as well as the results of the own study conducted in 2005 to evaluate the effectiveness of Bifiform® containing two probiotic strains: B. longum107 and Enterococcus faecium10 7 in the treatment of HP-associated gastroduodenal diseases in children. After the treatment course with Bifiform, there was an increase of SIgA in gastric biopsy samples, a significant reduction of IgE in the blood, and an increase in phagocytic activity. Hp eradication was achieved in 82% of patients in the intervention group and 72% in the comparison group. Administration of Bifiform® probiotic in combination with the eradication therapy scheme improves efficacy of treatment due to an integrated, primarily immunomodulatory, action.
About the Authors
E. A. Kornienko
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
S. N. Minina
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
References
1. Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS. Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccha-ride-activated Toll-like receptor 4. World J. Gastroenterol, 2008, 28, 14(32): 5090-5095.
2. Gut microflora. Digestive physiology and pathology. Ed.JC Rambaud, JP Buts, G Corthier, B Florie. John Libbey Eurotext, Paris, 2006, 248.
3. Gotteland M, Poliak L, Cruchet S, Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophi-lus in children colonised by Helicobacter pylori. Acta Paediatr, 2005, 94: 1747-1751.
4. Симаненков В.И, Суворов А.Н. Роль пробиотиков в проблеме эрадикации H. pylori. Дисбиоз кишечника. Под ред. Е.И. Ткаченко, А.Н. Суворова. СПб., 2007: 108-114.
5. Cindoruk M, Erkan G, Karakan T, Dursun A, et al. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double blind stude. Helicobacter, 2007, 12, 4: 309-316.
6. Lionetti E, Miniello VL, Castellaneta SP, Magista AM et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment. Pharmacol. Ther, 2006, 24: 1461-1468.
7. Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA. Bacillus clausii therapy to reduce side effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment. Pharmacol. Ther, 2004, 20: 1181-1188.
8. Cremonini F, Di Caro S, Covino M, Armuzzi A, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group< triple blind< placebo-controlled study. Am. J. Gastroenterol, 2002, 97: 2744-2749.
9. Sykora J, Valeckova K, Amlerova J, Siala K, et al. Effect of specially designed fermented milk product containing probiotic Lactobacillus casei DN-114001 and the eradication of H. pylori in children. J. Clin. Gastroenterol, 2005, 39: 692-698.
10. Sachdeva A, Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur. J. Gastroenterol. Hepatol, 2009, 21(1): 45-53.
11. Malfertheiner P, Megraud F, O'Morain C.A, et al. Management of Helicobacter pylori infection -the Maastricht IV/Florence Consensus report. Gut. 2012, 61: 646-664.
12. FAO/WHO. Working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for the evaluation of probiotics in food. 2002. ftp//ftp.fao.org/es/esn/food/wgre-port2.pdf.
13. Supplementation of infant formula with probi-otics and/or prebiotics: a systemic rewiew and comment by the ESPGHAN Commitee on Nutrition. J. Pediatr. Gastroenterol, 2011, 52(2): 238-250.
14. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr, 2001, 73, 2: 399-405.
15. Корниенко Е.А., Дроздова С.Н., Серебрянная Н.Б. Пробиотики как способ повышения эффективности эрадикации Helicobacter pylori у детей. Детская гастроэнтерология и нутрициология, 2005, 13, 3: 38-39.
16. Бондаренко В.М. Поликомпонентные пробиотики: механизм действия и терапевтический эффект при дисбиозах кишечника. Фарматека, 2005, 20: 46-54
Review
For citations:
Kornienko EA, Minina SN. Probiotics in the treatment of helicobacter pylori infection. Meditsinskiy sovet = Medical Council. 2015;(14):69-72. (In Russ.) https://doi.org/10.21518/2079-701X-2015-14-69-72
Views:
1920
Email this article 